COVID-19 infection outcome in African American Renal Transplant recipients: Detroit Medical Center by Jarrin Tejada, Claudia, MD et al.
Wayne State University 
Medical Student Research Symposium School of Medicine 
January 2021 
COVID-19 infection outcome in African American Renal 
Transplant recipients: Detroit Medical Center 
Claudia Jarrin Tejada MD 
Mareena Zachariah MD 
Wayne State University School of Medicine 
Angela Cruz MD 
Detroit Medical Center - Wayne State University 
Shakir Hussein MD 
Detroit Medical Center - Wayne State University 
Elizabeth Wilpula PharmD 
DMC Harper Hospital 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.wayne.edu/som_srs 
 Part of the Infectious Disease Commons, Nephrology Commons, and the Virus Diseases Commons 
Recommended Citation 
Jarrin Tejada, Claudia MD; Zachariah, Mareena MD; Cruz, Angela MD; Hussein, Shakir MD; Wilpula, 
Elizabeth PharmD; Meeks, Nicole; Wolff, Jeffrey A. MSN, AGACNP-BC; and Chandrasekar, Pranatharthi 
MD, "COVID-19 infection outcome in African American Renal Transplant recipients: Detroit Medical 
Center" (2021). Medical Student Research Symposium. 103. 
https://digitalcommons.wayne.edu/som_srs/103 
This Research Abstract is brought to you for free and open access by the School of Medicine at 
DigitalCommons@WayneState. It has been accepted for inclusion in Medical Student Research Symposium by an 
authorized administrator of DigitalCommons@WayneState. 
Authors 
Claudia Jarrin Tejada MD; Mareena Zachariah MD; Angela Cruz MD; Shakir Hussein MD; Elizabeth Wilpula 
PharmD; Nicole Meeks; Jeffrey A. Wolff MSN, AGACNP-BC; and Pranatharthi Chandrasekar MD 
This research abstract is available at DigitalCommons@WayneState: https://digitalcommons.wayne.edu/som_srs/
103 
 
COVID-19 infection outcome in African American Renal Transplant recipients: Detroit Medical 
Center 
 
Background:  Transplant recipients are more vulnerable to infections including COVID-19, given 
their comorbidities and chronic immunosuppression. Most preliminary care series report rapid 
clinical progression and higher mortality compared to the general population.   
Methods: Retrospective study at Harper University Hospital - Detroit Medical Center. Twenty-
five renal transplant recipients (RTR) presenting consecutively with COVID-19 symptoms and 
positive NP swab PCR for SARS-CoV2 between 03/01/2020 - 05/01/2020 were included. Data on 
demographics, clinical presentation, laboratory findings, management and outcomes were 
collected.  
Results: Patients had a median age of 56, all African American and deceased donor transplant 
recipients. Most had hypertension (96%), about half (52%) had diabetes, 64% had pulmonary 
disease including obstructive sleep apnea, COPD and pulmonary hypertension. Most common 
presenting symptom was dyspnea (64%), followed by fever and cough (56%) and diarrhea 
(56%). Half of patients had multifocal opacities on initial chest x-ray (52%). Immunosuppression 
with tacrolimus and low dose prednisone was continued, while mycophenolate mofetil was 
held on admission. Following institution guidelines, hydroxychloroquine was given to 32% who 
met criteria for risk of severe disease, while 48% received both hydroxychloroquine and 
steroids. Prophylactic anticoagulation was given to 80% of patients, while therapeutic 
coagulation to 8%. Oxygen supplementation given to 60% of patients and one patient required 
intubation. Three patients (12%) were admitted to intensive care, of which one expired. 
Treatment with mycophenolate was reintroduced based on resolution of symptoms and 
laboratory parameters.  
Conclusion: COVID-19 infected RTR in this cohort had lower mortality of 4% (n=1) compared to 
State-wide mortality of 10%. Clinical presentation was similar to non-immunocompromised 
hosts, but diarrhea was common. Despite multiple co-morbidities and chronic 
immunosuppression, our patient cohort had favorable outcome and lower mortality compared 
to other series. Exact reasons for this optimal outcome are unclear.   
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